Cancer Query

DRUGSURV is based on 44 clinical cancer expression datasets covering 17 different cancers. Table C1 reports available cancer types. You can view top associated drugs for each cancer (click the link "View top Drugs"). Table C2 reports available datasets. You can view top associated drugs for each dataset (click the link "View top Drugs").

Table C1. Cancer types

# Cancer Type Number of Expression Datasets View Associated Drugs
1 breast cancer 17 View top Drugs
2 lung cancer 7 View top Drugs
3 ovarian cancer 4 View top Drugs
4 colon cancer 2 View top Drugs
5 chronic lymphocytic leukemia 2 View top Drugs
6 hepatocellular carcinoma 2 View top Drugs
7 cervical cancer 1 View top Drugs
8 diffuse large b cell lymphoma 1 View top Drugs
9 prostate cancer 1 View top Drugs
10 glioblastoma 1 View top Drugs
11 astrocytic gliomas 1 View top Drugs
12 meningioma 1 View top Drugs
13 high-grade glioma 1 View top Drugs
14 liposarcoma 1 View top Drugs
15 bladder cancer 1 View top Drugs
16 multiple myeloma 1 View top Drugs
17 urothelial carcinomas 1 View top Drugs

Table C2. Clinical expression datasets

# GEO Dataset Cancer Type View Associated Drugs
1 heterogeneity of response to chemotherapy and recurrence-free survival in neoadjuvant breast cancer: results from the i-spy 1 trial breast cancer View top Drugs
2 183 breast tumors from the helsinki univerisity central hospital with survival information breast cancer View top Drugs
3 validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer breast cancer View top Drugs
4 search for a gene-expression signature of breast cancer local recurrence in young women breast cancer View top Drugs
5 a compact vegf signature associated with distant metastases and poor outcomes breast cancer View top Drugs
6 an expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival breast cancer View top Drugs
7 gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis breast cancer View top Drugs
8 strong time dependence of the 76-gene prognostic signature breast cancer View top Drugs
9 discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer breast cancer View top Drugs
10 the humoral immune system has a key prognostic impact in node-negative breast cancer breast cancer View top Drugs
11 endocrine sensitivity index validation dataset breast cancer View top Drugs
12 down-regulation of ecrg4, a candidate tumor suppressor gene in human breast cancer breast cancer View top Drugs
13 molecular characterization of breast cancer subtypes derived from joint analysis of high throughput mirna and mrna data breast cancer View top Drugs
14 analysis of early primary breast cancer to identify prognostic markers and associated pathways: mrna and mirna profiling breast cancer View top Drugs
15 a gene expression signature identifies two prognostic subgroups of basal breast cancer breast cancer View top Drugs
16 breast cancer relapse free survival breast cancer View top Drugs
17 gene expression of breast cancer tissue in a large population-based cohort of swedish patients breast cancer View top Drugs
18 gene expression data for pathological stage i-ii lung adenocarcinomas lung cancer View top Drugs
19 a gene expression signature to predict metastasis and survival in non-small cell lung cancer lung cancer View top Drugs
20 expression profile-defined classification of lung adenocarcinoma lung cancer View top Drugs
21 expression data for early stage nsclc lung cancer View top Drugs
22 human lung adenocarcinoma lung cancer View top Drugs
23 relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis lung cancer View top Drugs
24 gene expression signatures for predicting prognosis of squamous cell lung carcinomas lung cancer View top Drugs
25 a prognostic gene expression index in ovarian cancer ovarian cancer View top Drugs
26 a gene signature predicting for survival in suboptimally debulked patients with ovarian cancer ovarian cancer View top Drugs
27 prediction of progression-free survival in patients with advanced-stage serous ovarian cancer ovarian cancer View top Drugs
28 survival related profile, pathways and transcription factors in ovarian cancer ovarian cancer View top Drugs
29 metastasis gene expression profile predicts recurrence and death in colon cancer patients (moffitt samples) colon cancer View top Drugs
30 experimentally derived metastasis gene expression profile predicts recurrence and death in colon cancer patients colon cancer View top Drugs
31 expression data from untreated cll patients chronic lymphocytic leukemia View top Drugs
32 an eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia chronic lymphocytic leukemia View top Drugs
33 gene expression in fixed tissues and outcome in hepatocellular carcinoma hepatocellular carcinoma View top Drugs
34 combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma hepatocellular carcinoma View top Drugs
35 cervical cancer cervical cancer View top Drugs
36 prediction of survival in diffuse large b cell lymphoma treated with chemotherapy plus rituximab diffuse large b cell lymphoma View top Drugs
37 molecular sampling of prostate cancer: a dilemma for predicting disease progression prostate cancer View top Drugs
38 gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age glioblastoma View top Drugs
39 genome-wide profiling of astrocytic gliomas astrocytic gliomas View top Drugs
40 human meningioma fixed tumour tissue meningioma View top Drugs
41 molecular subclasses of high-grade glioma: prognosis, disease progression, and neurogenesis high-grade glioma View top Drugs
42 whole-transcript expression data for liposarcoma liposarcoma View top Drugs
43 predective value of prognosis-related gene expression study in primary bladder cancer bladder cancer View top Drugs
44 maqc-ii project: multiple myeloma (mm) data set multiple myeloma View top Drugs
45 subtype classification, grading, and outcome prediction of urothelial carcinomas by combined mrna profiling and acgh urothelial carcinomas View top Drugs


Feel free to use our tools at bioprofiling.de: